002219.SZ
新里程
SZSE · Healthcare · Q 卫生 · CN
CNY 2.13
−4.48%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.0B | 3.1B | 3.8B | 3.9B | 3.2B |
| Cost of Revenue | 2.1B | 2.2B | 2.6B | 2.7B | 2.2B |
| Gross Profit | 876.6M | 879.4M | 1.2B | 1.2B | 992.7M |
| Operating Expenses | |||||
| R&D Expense | 14.4M | 13.4M | 9.9M | 27.7M | 237.9K |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 357.0M | 371.2M | 510.8M | 658.4M | 407.1M |
| Selling & Marketing Expense | 193.1M | 204.9M | 294.4M | 216.3M | 283.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 707.7M | 731.6M | 966.2M | 1.0B | 842.4M |
| Cost and Expenses | 2.8B | 2.9B | 3.6B | 3.8B | 3.0B |
| Operating Income (EBIT) | 80.7M | 85.3M | 162.5M | 35.8M | 189.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 74.4M | 78.0M | 154.2M | 9.1M | 187.6M |
| Income Tax Expense | 45.1M | 44.5M | 33.9M | (28.8M) | 22.7M |
| Bottom Line | |||||
| Net Income | 25.8M | 30.9M | 114.8M | 27.0M | 156.1M |
| Earnings from Cont. Ops | 29.3M | 33.5M | 120.3M | 37.9M | 164.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 25.8M | 30.9M | 114.8M | 27.0M | 156.1M |
| Per Share | |||||
| Basic EPS | CN¥0.01 | CN¥0.01 | CN¥0.03 | CN¥0.01 | CN¥0.05 |
| Diluted EPS | CN¥0.01 | CN¥0.01 | CN¥0.03 | CN¥0.01 | CN¥0.05 |
| Revenue Per Share | CN¥0.87 | CN¥0.93 | CN¥1.16 | CN¥1.16 | CN¥0.97 |
| Shares | |||||
| Basic Shares Outstanding | 3.4B | 3.3B | 3.3B | 3.4B | 3.3B |
| Diluted Shares Outstanding | 3.4B | 3.3B | 3.3B | 3.4B | 3.3B |
| Profitability Metrics | |||||
| EBITDA | — | 276.9M | 364.5M | 273.2M | 363.9M |
| D&A | — | 191.6M | 202.1M | 237.5M | 174.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026